Dr. Steinman is a professor of Neurology and Neurological Sciences, Pediatrics, and Genetics at Stanford University.  He also served as the Chair of the Stanford University Interdepartmental Program in Immunology from 2003-2011. Dr. Steinman’s research focuses on what provokes relapses and remission in multiple sclerosis (MS), the nature of the molecules that serve as a brake on the brain inflammation, and the quest for a tolerizing vaccine for autoimmune diseases like type 1 diabetes and neuromyelitis optica.  He has developed two antigen specific therapies, using DNA vaccines, for MS and type 1 diabetes.  He was senior author on the seminal 1992 Nature article that reported the key role of a particular integrin in brain inflammation.  This research led to the development of the drug Tysabri, which is used to treat patients with MS and Crohn’s disease. Dr. Steinman received his BA from Dartmouth College and his MD degree from Harvard University. He was a post-doctoral fellow in chemical immunology fellow at the Weizmann Institute of Science in Israel. Dr. Steinman returned to Stanford University Hospital as a resident in pediatric and adult neurology and then joined the faculty at Stanford in 1980.